PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 1, 2015, Pages 139-146

  Shen, Jiayun ^a   Wong, Grace Lai Hung ^a   Chan, Henry Lik Yuen ^a   Chan, Ruth Suk Mei ^a   Chan, Hoi Yun ^a   Chu, Winnie Chiu Wing ^a   Cheung, Bernice Ho Ki ^a   Yeung, David Ka Wai ^b   Li, Liz Sin ^a   Sea, Mandy Man Mei ^a   Woo, Jean ^a   Wong, Vincent Wai Sun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Magnetic resonance spectroscopy; Non alcoholic steatohepatitis; Obesity; Transient elastography; Weight loss

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PATATIN LIKE PHOSPHOLIPASE 3; PHOSPHOLIPASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ADULT; ALLELE; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LIVER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; REMISSION; RIGIDITY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; FATTY LIVER; GENETIC POLYMORPHISM; GENETICS; LIFESTYLE; METABOLISM; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ALLELES; BODY MASS INDEX; FATTY LIVER; FEMALE; HUMANS; LIFE STYLE; LIPASE; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES;

EID: 84919685089     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12656     Document Type: Article

References (25)

1. Williams CD, Stengel J, Asike MI etal. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-131.
2. Wong VW, Chu WC, Wong GL etal. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61: 409-415.
3. Wong VW, Wong GL, Choi PC etal. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-974.
4. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972-1978.
5. Bhala N, Angulo P, van der Poorten D etal. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 2011; 54: 1208-1216.
6. Promrat K, Kleiner DE, Niemeier HM etal. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010; 51: 121-129.
7. Haufe S, Engeli S, Kast P etal. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 2011; 53: 1504-1514.
8. Wong VW, Chan RS, Wong GL etal. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J. Hepatol. 2013; 59: 536-542.
9. Romeo S, Kozlitina J, Xing C etal. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 2008; 40: 1461-1465.
10. Yuan X, Waterworth D, Perry JR etal. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. 2008; 83: 520-528.
11. Kantartzis K, Peter A, Machicao F etal. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 2009; 58: 2616-2623.
12. Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, Nash CRN. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52: 894-903.
13. Santoro N, Kursawe R, D'Adamo E etal. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 2010; 52: 1281-1290.
14. Speliotes EK, Butler JL, Palmer CD etal. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010; 52: 904-912.
15. Valenti L, Alisi A, Galmozzi E etal. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010; 52: 1274-1280.
16. Hyysalo J, Stojkovic I, Kotronen A etal. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2012; 27: 951-956.
17. Petta S, Grimaudo S, Camma C etal. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. J. Hepatol. 2012; 56: 1356-1362.
18. Shen J, Wong GL, Chan HL etal. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. Aliment. Pharmacol. Ther. 2014; 39: 532-539.
19. He S, McPhaul C, Li JZ etal. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 2010; 285: 6706-6715.
20. Perttila J, Huaman-Samanez C, Caron S etal. PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis. Am. J. Physiol. Endocrinol. Metab. 2012; 302: E1063-1069.
21. Pirazzi C, Adiels M, Burza MA etal. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J. Hepatol. 2012; 57: 1276-1282.
22. Kumashiro N, Yoshimura T, Cantley JL etal. Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats. Hepatology 2013; 57: 1763-1772.
23. Sevastianova K, Kotronen A, Gastaldelli A etal. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. Am. J. Clin. Nutr. 2011; 94: 104-111.
24. Wong VW, Vergniol J, Wong GL etal. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-462.
25. Marzuillo P, Grandone A, Perrone L, del Giudice EM. Weight loss allows the dissection of the interaction between abdominal fat and PNPLA3 (adiponutrin) in the liver damage of obese children. J. Hepatol. 2013; 59: 1143-1144.